Article summary
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued additional information on the regulatory approval of the coronavirus (COVID-19) Moderna vaccine. In particular, the MHRA has provided an updated public assessment report following the grant of conditional marketing authorisation. The public assessment report explains how the Moderna vaccine was assessed and its authorisation recommended, as well as its conditions of use.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial